Bio
Dr. Davud Baradaran Sirjani graduated with a 4.0 in Biochemistry from the University of Arizona, where he received the College of Science’s Most Outstanding Senior Award and the Centennial Achievement Award. He subsequently matriculated to the University of Arizona College of Medicine as a Dean’s Scholar.
He completed his residency in Otolaryngology–Head and Neck Surgery at Washington University in St. Louis, two years of NIH research on cochlear electrophysiology and followed by advanced fellowship training in Head and Neck Oncology and Microvascular Reconstruction at University of Washington in Seattle.
Dr. Sirjani joined the faculty at Stanford University School of Medicine in 2009 and has served as Chief of Otolaryngology at the VA Palo Alto Health Care System since 2012. Under his leadership, the VA otolaryngology program has experienced substantial growth in clinical volume, access, and regional impact, expanding its reach and complexity of care across California and the broader VA network.
A national leader in telemedicine, Dr. Sirjani pioneered innovative care delivery models to improve access to complex head and neck cancer care for veterans. In 2012, he established the VA Palo Alto Head and Neck Cancer Telemedicine Program, which has grown into the largest programs of its kind in the United States. This initiative connects patients across geographically underserved regions—including the Pacific Islands and Mountain West—to subspecialty expertise at the Stanford VA, improving timeliness of care, surgical triage, and oncologic outcomes.
Dr. Sirjani has served as Director of the Salivary Gland Program at Stanford since 2013, where his clinical practice focuses on minimally invasive approaches to parotid and salivary gland disease. He was the first surgeon at Stanford to introduce sialendoscopy, significantly expanding gland-preserving treatment options. His work emphasizes reducing morbidity, preserving facial nerve function, and optimizing functional and aesthetic outcomes in both benign and malignant disease. Currently, he is the most experience surgeon to treat Peomorphic adenomas of the parotid given his novel surgical technique.
His research and innovation efforts center on surgical simulation, intraoperative nerve protection, and techniques to minimize complications in head and neck surgery. Dr. Sirjani developed one of the only parotidectomy surgical simulators in the country, supported by CIMIT, which is used to train surgeons in facial nerve preservation and operative precision. His work bridges engineering, education, and clinical care, advancing both surgical training and patient safety.
Clinically, Dr. Sirjani is known for high-volume expertise in complex salivary and head and neck oncologic surgery, with a focus on efficiency, precision, and patient-centered outcomes. He integrates advanced technology, data-driven decision-making, and multidisciplinary collaboration to streamline care—from initial consultation and remote triage to definitive surgical management and reconstruction.
Through his dual leadership roles at Stanford and the VA, Dr. Sirjani has built programs that emphasize innovation, access, and excellence in care delivery. His contributions continue to shape modern approaches to head and neck cancer treatment, surgical education, and telehealth-enabled specialty care.
